2009 H1N1 influenza A in children: a descriptive clinical study

Maha Mahmoud Hamdi Khalil Mansour1, Khalid Mohamed Abdullah Al Hadidib

  • 1Pediatric Department, Cairo University, Cairo, Egypt, Clinical Pathology Department, Ain Shams University, Cairo, Egypt. fractaledge3@yahoo.com

Annals of Saudi Medicine
|December 14, 2011
PubMed

Insights

The 2009 pandemic influenza A H1N1 virus caused severe illness in children, with those under 5 years old at higher risk. Early diagnosis using clinical signs and lymphopenia aided prompt antiviral treatment, preventing fatalities.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Epidemiology

Background:

  • The 2009 H1N1 influenza virus posed a significant threat, particularly to young children and individuals with pre-existing medical conditions.
  • Influenza-related complications were more prevalent in specific high-risk pediatric age groups.

Purpose of the Study:

  • To detail the clinical presentation of H1N1 cases in pediatric patients at Jeddah Clinic Hospital-Al Kandarah (JCH-K).
  • To identify high-risk age groups for severe H1N1 influenza complications.
  • To evaluate diagnostic criteria for early antiviral intervention.

Main Methods:

  • A prospective study was conducted at JCH-K from October 2009 to January 2010.
  • Pediatric patients (up to 15 years) with influenza-like illnesses were clinically assessed and tested via reverse transcriptase polymerase chain reaction (RT-PCR).
  • Confirmed H1N1 cases were analyzed for clinical symptoms, demographic data, and outcomes.

Main Results:

  • Eighty-nine laboratory-confirmed H1N1 cases were reported, with 38.2% of patients younger than 5 years.
  • Fever was universal; pneumonia occurred in 31.5% of cases. Asthmatic children represented 15.7%.
  • Lymphopenia (58.4%) and leucopenia (35.9%) were common. Hospitalization was required for 73%, with 5.6% needing intensive care.

Conclusions:

  • Despite a generally mild presentation, severe H1N1 influenza occurred in children.
  • Clinical presentation and lymphopenia served as crucial early diagnostic markers for initiating antiviral therapy, especially with delayed PCR results.
  • No deaths were associated with the 2009 pandemic influenza A H1N1 in this cohort.
Abstract